Literature DB >> 32586146

GINA 2020: What's new and why?

Pranav Ish1, Nipun Malhotra1, Nitesh Gupta1.   

Abstract

Entities:  

Keywords:  COVID-19; asthma; changes; guidelines; update

Year:  2020        PMID： 32586146     DOI： 10.1080/02770903.2020.1788076

Source DB:  PubMed          Journal:  J Asthma        ISSN： 0277-0903            Impact factor:   2.515


× No keyword cloud information.
  8 in total

1.  Identification of potential biomarkers and immune infiltration characteristics in severe asthma.

Authors:  Yuanyuan Jiang; Shuanglinzi Deng; Xinyue Hu; Lisha Luo; Yingyu Zhang; Daimo Zhang; Xiaozhao Li; Juntao Feng
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

2.  A real-world implementation of asthma clinic: Make it easy for asthma with Easy Asthma Clinic.

Authors:  Watchara Boonsawat; Kittisak Sawanyawisuth
Journal:  World Allergy Organ J       Date:  2022-10-07       Impact factor: 5.516

3.  Needs and expectations for an AR program for asthma education for school-age children in South Korea: The perspectives of children, parents, and teachers.

Authors:  Yunsoo Kim; Hyojin Ju
Journal:  Child Health Nurs Res       Date:  2021-10-31

4.  Relationships Between Bronchodilators, Steroids, Antiarrhythmic Drugs, Antidepressants, and Benzodiazepines and Heart Disease and Ischemic Stroke in Patients With Predominant Bronchiectasis and Asthma.

Authors:  Jun-Jun Yeh; Mei-Chu Lai; Yu-Cih Yang; Chung-Y Hsu; Chia-Hung Kao
Journal:  Front Cardiovasc Med       Date:  2022-02-17

5.  Comparative effectiveness of oral dexamethasone vs. oral prednisolone for acute exacerbation of asthma: A randomized control trial.

Authors:  Bhaskar Banoth; Anjali Verma; Kapil Bhalla; Alok Khanna; Saraswathi Holla; Swati Yadav
Journal:  J Family Med Prim Care       Date:  2022-03-18

6.  Knowledge, attitude, and practice of pharmacists regarding asthma management: a cross-sectional study in Egypt.

Authors:  Amira S A Said; Nadia Hussain; Zelal Kharaba; Amal H I Al Haddad; Lamiaa N Abdelaty; Raghda R S Hussein
Journal:  J Pharm Policy Pract       Date:  2022-05-03

7.  Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.

Authors:  Lingna Xue; Cui Li; Guangbo Ge; Shaoyan Zhang; Liming Tian; Yu Wang; Huiyong Zhang; Zifeng Ma; Zhenhui Lu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 8.  Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity.

Authors:  Petros Bakakos; Konstantinos Kostikas; Stelios Loukides; Michael Makris; Nikolaos G Papadopoulos; Paschalis Steiropoulos; Stavros Tryfon; Eleftherios Zervas
Journal:  J Pers Med       Date:  2022-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.